Can you take Wegovy for life — and what happens if you stop?

You've been on Wegovy for a year and the question changes

For the first few months, most people are focused on tolerating the dose escalation and watching the scales move. Somewhere around the six-month mark, a different question tends to surface: is this something I'll need to keep taking, the way someone with high blood pressure takes their medication indefinitely? That shift in thinking is a healthy one. Obesity is a chronic, relapsing condition with biological drivers (hunger hormones, metabolic adaptations, genetic predisposition) that don't simply resolve once weight comes off. Semaglutide works by acting on GLP-1 receptors to reduce appetite and slow gastric emptying; when you stop taking it, those effects stop too.

The STEP 1 trial, published in the New England Journal of Medicine, followed participants beyond the active treatment period and found that most people regained the majority of lost weight within a year of stopping, their weight, waist circumference and cardiometabolic markers largely returned to pre-treatment levels. That is not a failure of willpower; it is what the biology predicts. It is also one of the strongest arguments for thinking about Wegovy as an ongoing tool rather than a short course.

If you recognise yourself in that scenario (maintaining well, wondering whether to continue) the conversation to have is with your prescriber, not a forum. You can also read accounts from people for whom Wegovy changed their life in ways that went well beyond the number on the scales.

How long does UK guidance say you can take it?

The answer splits depending on whether you are accessing Wegovy through the NHS or privately. Under NICE's appraisal of semaglutide (TA875), NHS use is restricted to a maximum of two years, within a specialist weight management service that includes multidisciplinary support. If less than five percent of body weight has been lost after six months at the maintenance dose, continuing is not recommended under NHS criteria. Those parameters are specific to the NHS commissioning framework.

Private prescribing operates under the medicine's licence rather than the NICE commissioning recommendation. The Wegovy licence itself sets no maximum treatment duration: it authorises use in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. A prescriber can lawfully continue treatment for as long as the clinical picture supports it. What that requires in practice is regular review, not a rubber stamp, but a genuine reassessment of benefit and risk. If you are wondering whether you can stay on Wegovy for life, the honest answer depends on your individual health picture and the outcome of those ongoing clinical conversations.

Questions about whether Wegovy is a lifelong medicine ultimately depend on individual health goals and how someone's body responds; there is no single answer that fits everyone.

What stopping actually looks like (and what it means for planning

Some people do come off Wegovy intentionally) after reaching a stable weight they are confident they can maintain through diet and activity alone, after a planned pregnancy (the medicine is not recommended during pregnancy, breastfeeding, or when trying to conceive), or because of side effects that outweigh the benefit. That is a legitimate path. What clinical evidence makes clear is that stopping should be planned with a prescriber, not just forgotten when a pen runs out.

For those who stay on treatment long-term, routine becomes part of it. Many people keep their weekly pen in the fridge door beside everyday items and inject on the same evening each week; the predictability helps. Side effects, mostly gastrointestinal (nausea, changes in digestion, occasional fatigue) tend to settle after the initial dose increases and are much less noticeable at a stable maintenance dose. You can read more about how Wegovy works and what to expect on our Wegovy overview page.

Cost is a real consideration for long-term private use. UK private prices vary by dose and provider; the context around Wegovy pricing in the UK is worth understanding before committing to treatment. At nume, one transparent price covers the consultation, prescription, and free next-working-day delivery, no subscription, no hidden fees, and a prescriber reviews the case before every repeat.

Some people also notice unexpected changes during treatment, feeling persistently cold is one that comes up more often than you might expect, and it has a plausible physiological explanation worth knowing about.

The clinical picture that determines continuation

A prescriber considering long-term Wegovy use is weighing several things: the ongoing benefit in terms of weight and any related health conditions; whether the treatment is still tolerated; any new information about the person's health since the last review; and whether the original indication still applies. That is not a bureaucratic exercise. For someone managing high blood pressure, sleep apnoea or joint problems alongside their weight, the medicine may be doing useful work beyond the number on the scales.

The NHS medicines information for semaglutide notes that the treatment is intended to be used alongside lifestyle changes, not instead of them, and that remains true at any duration. Prescribers at services like ours, staffed by GPhC-registered Independent Prescribers who review every order personally, are well placed to have that continuing conversation.

If you are thinking about starting or continuing weight management treatment and want a clinical view on what's right for your situation, our free consultation is the place to begin. There are no obligations and no automated decisions, a real prescriber reads every response.